
Gottlieb continues to be Trump's leading candidate for FDA; BeyondSpring completes unusual IPO
→ Scott Gottlieb is President Trump’s leading choice for FDA commissioner, Bloomberg now reports, citing “people” familiar with the matter. BioCentury had the scoop in mid-February.
→ BeyondSpring, a biotech with deep roots in China, has completed an unusual IPO this week. After initially targeting an offering designed to raise $100 million, the biotech ended up selling 174,286 shares at $20 and then executed a private offering to insiders for another 2.5 million shares. The total amounted to $54 million. The company has a cancer drug in several studies.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.